Uveitis in juvenile Behçet's disease: clinical course and visual outcome compared with adult patients

被引：0
作者：
M Kramer
R Amer
M Mukamel
M Snir
T Jaouni
R Friling
机构：
[1] Rabin Medical Center,Department of Ophthalmology
[2] Hadassah Medical Center,Department of Ophthalmology
[3] Hadassah School of Medicine,undefined
[4] Hebrew University,undefined
[5] Pediatric Rheumatology Unit,undefined
[6] Schneider Children's Medical Center of Israel,undefined
[7] Pediatric Ophthalmology Unit,undefined
[8] Schneider Children's Medical Center of Israel,undefined
[9] Sackler School of Medicine,undefined
[10] Tel Aviv University,undefined
来源：
Eye | 2009年 / 23卷
关键词：
Behçet's disease; juvenile; uveitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2034 / 2041
页数：7
相关论文
共 50 条
  • [21] Significant association of HLA-A26 with uveitis and gastrointestinal involvement in patients with Behçet's disease in a multicentre study
    Nakajima, Tomoya
    Tsuji, Hideaki
    Inaba, Ryuta
    Saito, Rintaro
    Nishimura, Keisuke
    Morinobu, Akio
    MODERN RHEUMATOLOGY, 2024, 34 (06) : 1221 - 1225
  • [22] Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet’s disease by infliximab treatment
    Masaru Takeuchi
    Kozo Harimoto
    Manzo Taguchi
    Yutaka Sakurai
    BMC Ophthalmology, 15
  • [23] Serum vitronectin levels in patients with Behçet’s disease
    Ali Yalçındağ
    Aslıhan Uzun
    F. Nilüfer Yalçındağ
    Namık Delibaş
    Inflammation Research, 2012, 61 : 1241 - 1246
  • [24] Serum vitronectin levels in patients with Beh‡et's disease
    Yalcindag, Ali
    Uzun, Aslihan
    Yalcindag, F. Nilufer
    Delibas, Namik
    INFLAMMATION RESEARCH, 2012, 61 (11) : 1241 - 1246
  • [25] Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review
    Ana Urruticoechea-Arana
    Tatiana Cobo-Ibáñez
    Virginia Villaverde-García
    Montserrat Santos Gómez
    Estíbaliz Loza
    Kelly Vargas-Osorio
    Leslie Fariñas Padrón
    Federico Diaz-Gonzalez
    Vanesa Calvo-Río
    Ricardo Blanco
    Rheumatology International, 2019, 39 : 47 - 58
  • [26] Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet’s disease
    Sunao Sugita
    Yuko Kawazoe
    Ayano Imai
    Yukiko Yamada
    Shintaro Horie
    Manabu Mochizuki
    Arthritis Research & Therapy, 14
  • [27] Effects of infliximab in the treatment of refractory posterior uveitis of Behçet's disease after withdrawal of infusions
    Adán A.
    Hernandez V.
    Ortiz S.
    Molina J.J.
    Pelegrin L.
    Espinosa G.
    Sanmartí R.
    International Ophthalmology, 2010, 30 (5) : 577 - 581
  • [28] Acquired resistance to infliximab against uveitis due to Behçet’s disease after one year of administration
    Takako Ito
    Koh-Hei Sonoda
    Kuniaki Hijioka
    Takeshi Fujimoto
    Tatsuro Ishibashi
    Japanese Journal of Ophthalmology, 2010, 54 : 502 - 504
  • [29] Efficacy and safety of adalimumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study
    Claudia Fabiani
    Antonio Vitale
    Giacomo Emmi
    Lorenzo Vannozzi
    Giuseppe Lopalco
    Silvana Guerriero
    Ida Orlando
    Rossella Franceschini
    Daniela Bacherini
    Luca Cimino
    Alessandra Soriano
    Bruno Frediani
    Mauro Galeazzi
    Florenzo Iannone
    Gian Marco Tosi
    Carlo Salvarani
    Luca Cantarini
    Clinical Rheumatology, 2017, 36 : 183 - 189
  • [30] Efficacy and safety of adalimumab in Beh‡et's disease-related uveitis: a multicenter retrospective observational study
    Fabiani, Claudia
    Vitale, Antonio
    Emmi, Giacomo
    Vannozzi, Lorenzo
    Lopalco, Giuseppe
    Guerriero, Silvana
    Orlando, Ida
    Franceschini, Rossella
    Bacherini, Daniela
    Cimino, Luca
    Soriano, Alessandra
    Frediani, Bruno
    Galeazzi, Mauro
    Iannone, Florenzo
    Tosi, Gian Marco
    Salvarani, Carlo
    Cantarini, Luca
    CLINICAL RHEUMATOLOGY, 2017, 36 (01) : 183 - 189
12345